News

Insomnia severity more pronounced in older Hispanics


 

FROM THE AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY

References

Insomnia is a more pronounced problem than expected among Hispanics over age 50, according to results of a study by Christopher N. Kaufmann, PhD, and his coauthors.

Dr. Kaufmann and his colleagues studied 22,252 participants of white, Non-Hispanic black, Hispanic, or other race/ethnicity. Participant data came from a nationally representative survey from 2002 to 2010, in which patients rated the severity of four insomnia symptoms. All participants were adults older than 50 years.

Insomnia severity scores increased 0.19 points over time after the investigators controlled for sex, race/ethnicity, education, and baseline age (95% CI, 0.14-0.24; t = 7.52; design df = 56; P less than .001). After adjustment for accumulated health conditions and body mass index, this trend decreased, Dr. Kaufmann and his colleagues added. However, the increasing trajectory of insomnia severity was “significantly more pronounced” among Hispanics, compared with non-Hispanic whites, after adjustment for accumulated health conditions, body mass index, and number of depressive symptoms, the investigators said in the report.

Although health conditions can result in greater insomnia severity with age, “further research is needed to determine the reasons for a different insomnia trajectory among Hispanics,” the authors concluded.

Read the full article in the American Journal of Geriatric Psychiatry.

Recommended Reading

Age, lower baseline ALC increase dimethyl fumarate lymphopenia risk
MDedge Family Medicine
Midlife interventions help preserve later cognitive function
MDedge Family Medicine
PAWSS tool identifies alcohol withdrawal syndrome risk
MDedge Family Medicine
A new sort of consultant: Advising doctors, patients on California’s aid-in-dying law
MDedge Family Medicine
Recurrent DKA episodes found to trigger cognitive changes
MDedge Family Medicine
VIDEO: Smart insole system helped reduce reulceration risk
MDedge Family Medicine
Artificial pancreas can improve inpatient glycemic control in type 2 diabetes
MDedge Family Medicine
Sleep apnea in later life more than doubles subsequent Alzheimer’s risk
MDedge Family Medicine
FDA panel narrowly endorses empagliflozin’s cardiovascular mortality benefit
MDedge Family Medicine
Account for all medications, even if they’re banned
MDedge Family Medicine